COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,438 Articles (22,835 medRxiv, 8,603 bioRxiv)

Most recent first Previous |  Page 825: Articles 8241-8250  | Next

Faster SARS-CoV-2 sequence validation and annotation for GenBank using VADR
Nawrocki, E. P.
10.1101/2022.04.25.489427 — Posted: 2022-04-27
SARS-CoV-2 detection in wastewater as an early warning: the case of metropolitan area of the city of Buenos Aires (AMBA).
Barrio, A., Borro, V., Cicchino, M., Moron, A., Coronel, L., Vuolo, J., Mayon, P., Moroz, S., Maisa, P., Alcantara, S., Torras, M. A., Cervini Bohn, M., Arzeno, M., Godoy, C., Campillay, D., Filiel, N., Salas, A. C., Salvio, P.
10.1101/2022.04.23.22273730 — Posted: 2022-04-27
P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
Kuzmina, A., Atari, N., Ottolenghi, A., Korovin, D., Cohen Lass, I., Rosental, B., Rosenberg, E., Mandelboim, M., Taube, R.
10.1101/2022.04.26.489630 — Posted: 2022-04-27
The impact of COVID-19 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis
Sabeena, S., Ravishankar, N., Robin, S., Sasidharan Pillai, S.
10.1101/2022.04.26.22274244 — Posted: 2022-04-27
Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose
Brosh-Nissimov, T., Hussein, K., Wiener-Well, Y., Orenbuch-Harroch, E., Elbaz, M., Lipman-Arens, S., Maor, Y., Yagel, Y., Chazan, B., Hershman-Sarafov, M., Rahav, G., Zimhony, O., Zaidman Shimshovitz, A., Chowers, M.
10.1101/2022.04.24.22274237 — Posted: 2022-04-27
Health care use attributable to COVID-19: A propensity matched national electronic health records cohort study of 249,390 people in Wales, UK.
Kennedy, J., Parker, M., Seaborne, M., Mhereeg, M., Walker, A. J., Walker, V., Denaxas, S., Kennedy, N., Katikireddi, S. V., Brophy, S.
10.1101/2022.04.21.22274152 — Posted: 2022-04-27
Analyses of Omicron genomes from India reveal BA.2 as a more transmissible variant
Atkulwar, A., Rehman, A., Imaan, Y., Baig, M.
10.1101/2022.04.25.22274272 — Posted: 2022-04-27
Higher contact among vaccinated can be a mechanism for negative vaccine effectiveness
Bodner, K., Knight, J., Hamilton, M. A., Mishra, S.
10.1101/2022.04.25.22274266 — Posted: 2022-04-27
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Qasmieh, S., Robertson, M. M., Teasdale, C. A., Kulkarni, S. G., Nash, D.
10.1101/2022.04.23.22274214 — Posted: 2022-04-27
Workplace and lifestyle heterogeneity in subjective wellbeing: Latent Class Analysis of UK Time Use Survey before and during COVID-19
Chen, J., Wan, L.
10.1101/2022.04.27.22273297 — Posted: 2022-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).